[RDHL] YoY Quarter Result on 30-Sep-2020 [#Q3]

Stock
[RDHL] RedHill Biopharma Ltd.
Announcement Date
29-Sep-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- -16.15%
YoY- -89.51%
Quarter Report
RDHL's Result
RDHL's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 17,552 21,609 20,943 1,401 2,206 1,523 0 -
PBT -35,701 -21,387 -18,638 -9,835 -10,083 -15,512 -8,944 25.93%
Tax 28,593 17 42 170 133 150 109 152.90%
NP -64,294 -21,387 -18,638 -9,835 -10,083 -15,512 -8,944 38.90%
Tax Rate - - - - - - - -
Total Cost 81,846 42,996 39,581 11,236 12,289 17,035 8,944 44.60%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin -366.31 -98.97 -88.99 -702.00 -457.07 -1,018.52 0.00 -
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -40.29 -18.28 -19.99 -13.87 -17.17 -36.14 -28.07 6.20%
EPS Diluted -40.29 -18.28 -19.99 -13.87 -17.17 -36.14 -28.07 6.20%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.